Comprehensive Overview of Common Techniques and Application Scenarios in Post-translational Modifications (PTMs) Research
-
The low abundance of modification sites necessitates highly sensitive detection methods;
-
The diverse chemical properties of different modification types require tailored enrichment strategies;
-
The complexity of modification patterns demands high-resolution and precise mass spectrometry platforms for accurate characterization.
-
Phosphorylation: Enriched using materials such as IMAC (immobilized metal affinity chromatography), TiO₂ (titanium dioxide), and ZrO₂ (zirconium dioxide), which selectively capture phosphopeptides;
-
Acetylation and Methylation: Enriched primarily through site-specific immunoprecipitation using modification-specific antibodies;
-
Ubiquitination: Identified by the characteristic diglycine (“GG”) remnant left after proteolysis, typically enriched using anti-diglycine antibodies;
-
Glycosylation: Captured via lectin affinity techniques or hydrophilic interaction liquid chromatography (HILIC).
-
Isobaric Tagging (TMT/iTRAQ): Chemical tags are used to label multiple samples, which are then combined for simultaneous MS analysis, enabling parallel quantification;
-
SILAC (Stable Isotope Labeling by Amino Acids in Cell Culture): Introduces isotopic amino acids during cell growth to metabolically label proteins during synthesis;
-
Label-free Quantification: Relies on direct comparison of MS signal intensities, requiring high instrument stability but offering greater flexibility in sample throughput.
In the context of cellular life processes, proteins often do not attain full functionality immediately after synthesis. Many require post-translational modifications (PTMs) to regulate their structural stability, subcellular localization, molecular interactions, and biological activity. PTMs have emerged as a critical area in modern life sciences, with broad applications in elucidating disease mechanisms, validating drug targets, and discovering biomarkers.
Research Challenges in Post-Translational Modifications
More than 400 types of PTMs have been identified to date, with the most common forms including phosphorylation, acetylation, ubiquitination, glycosylation, methylation, and nitration. These modifications are typically transient and dynamically regulated, often occurring at low-abundance sites that represent only a small fraction of the total protein content. Furthermore, PTM occurrence is independent of overall protein abundance. These characteristics pose several technical challenges for research:
Commonly Used Technical Approaches
1. High-Resolution Mass Spectrometry (HR-MS)
HR-MS is the cornerstone of PTM research. Through liquid chromatography-tandem mass spectrometry (LC-MS/MS), researchers can achieve precise identification and quantification of modification sites at the peptide level. Common mass spectrometry platforms—such as Orbitrap, TOF, and FT-ICR—offer high sensitivity, resolution, and mass accuracy, making them suitable for detecting peptides with low-abundance modifications. In addition, search engines like MaxQuant, Proteome Discoverer, and MSFragger support variable modification settings, enabling the identification of both known and novel PTMs.
2. Peptide Enrichment Strategies for Modified Forms
Given that PTMs often occur on low-abundance proteins or rare sites, direct analysis frequently yields low signal-to-noise ratios, limiting data coverage. Enrichment techniques are therefore an essential preprocessing step in PTM workflows:
3. Quantitative Methods Based on Isotope Labeling
Quantitative strategies are crucial for comparing PTM levels across different experimental conditions. Common methods include:
4. Antibody-Based Validation and Immunodetection
Beyond mass spectrometry, certain PTMs can be validated using modification-specific antibodies in assays such as Western blot, ELISA, and immunohistochemistry (IHC). These approaches are particularly suited to targeted investigations, offering high specificity and clear visualization, and are frequently employed during mechanistic studies.
Main Application Scenarios
1. Signal Transduction Pathway Analysis
Post-translational Modifications (PTMs) serve as pivotal regulators in cellular signaling, with phosphorylation and ubiquitination playing central roles in orchestrating kinase cascades and protein degradation pathways. Investigating the dynamic alterations of PTMs facilitates the elucidation of molecular mechanisms underlying signaling events such as receptor activation and transcription factor regulation.
2. Tumor and Disease Mechanism Research
Aberrant PTMs are closely associated with a variety of diseases. For instance, hyperactivation of specific kinases in tumor cells can induce abnormal phosphorylation, resulting in dysregulated cell cycle progression. Moreover, dysregulation of the ubiquitin–proteasome system has been implicated as a key contributor to neurodegenerative disorders. PTM-omics approaches that uncover these abnormal modification landscapes provide valuable insights into disease initiation and progression.
3. Drug Target and Mechanism Validation
Many small-molecule therapeutics exert their effects by modulating PTM-regulated proteins. Comparative analysis of PTM profiles before and after treatment enables detailed characterization of drug mechanisms of action and downstream molecular responses.
4. Biomarker Discovery
Compared to protein expression levels, PTMs exhibit higher functional specificity and dynamic responsiveness, conferring a distinct advantage in biomarker identification. Large-scale PTM-omics studies are routinely employed to detect modification patterns that are tightly correlated with disease progression, offering promising candidates for clinical early detection and prognostic assessment.
5. Epigenetic Regulation Research
Histone modifications such as acetylation and methylation modulate chromatin accessibility and transcriptional activation, constituting key mechanisms of epigenetic regulation. Analyzing the spatial and temporal distribution of these modifications across developmental stages or disease contexts advances our understanding of gene expression regulatory networks.
Research into Post-translational Modifications (PTMs) has emerged as a critical branch of life sciences and is poised to play an increasingly vital role in systems biology, precision medicine, and targeted therapy. With ongoing advancements in mass spectrometry technologies, the continuous expansion of PTM databases, and the intelligent evolution of analytical algorithms, PTM research is reaching unprecedented levels of depth and resolution. In proteomics and PTMs studies, technical robustness and data interpretability remain the cornerstones of research efficiency. MtoZ Biolabs leverages high-resolution mass spectrometry platforms and tailored multi-omics solutions to deliver reliable, high-throughput, and precise PTM proteomics services, empowering researchers to effectively validate scientific hypotheses and accelerate translational outcomes.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
